Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Top Small Cap Stocks Worth Watching - October 23rd

AltC Acquisition logo with background
Image from MarketBeat Media, LLC.

Key Points

  • Seven small-cap stocks are highlighted: AltC Acquisition (ALCC), Spring Valley Acquisition (SV), Inflection Point Acquisition II (IPXX), BIO-key International (BKYI), J-Star (YMAT), Beazer Homes USA (BZH), and Bolt Biotherapeutics (BOLT). They ranked among the highest-dollar-volume small-cap stocks in recent trading.
  • The companies span diverse sectors, including acquisition vehicles, biometric identity software, homebuilding, and cancer immunotherapy. Notable operating businesses include BIO-key, Beazer Homes, and Bolt Biotherapeutics, whose lead candidate is being developed for HER2-positive solid tumors.
  • Small-cap stocks may offer greater growth potential but carry higher risk and volatility because they often have fewer financial resources and less-established market positions.
  • MarketBeat All Access makes it easier to follow AltC Acquisition with alerts, analyst ratings, and deeper research — now $149 a year with your rate locked in.

AltC Acquisition, Spring Valley Acquisition, Inflection Point Acquisition Corp. II, BIO-key International, J-Star, Beazer Homes USA, and Bolt Biotherapeutics are the seven Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations, typically ranking below large- and mid-cap companies by total market value. They may offer greater growth potential, but they generally involve higher volatility and risk because these companies often have fewer financial resources and less established market positions. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

Read Our Latest Research Report on ALCC

Spring Valley Acquisition (SV)

Read Our Latest Research Report on SV

Inflection Point Acquisition Corp. II (IPXX)

Read Our Latest Research Report on IPXX

BIO-key International (BKYI)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Read Our Latest Research Report on BKYI

J-Star (YMAT)

Read Our Latest Research Report on YMAT

Beazer Homes USA (BZH)

Beazer Homes USA, Inc. operates as a homebuilder in the United States. It designs, constructs, and sells single-family and multi-family homes under the Beazer Homes, Gatherings, and Choice Plans names. The company also sells its homes through commissioned new home sales counselors and independent brokers in Arizona, California, Nevada, Texas, Indiana, Delaware, Maryland, Tennessee, Virginia, Florida, Georgia, North Carolina, and South Carolina.

Read Our Latest Research Report on BZH

Bolt Biotherapeutics (BOLT)

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer.

Read Our Latest Research Report on BOLT

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AltC Acquisition Right Now?

Before you consider AltC Acquisition, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AltC Acquisition wasn't on the list.

While AltC Acquisition currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines